Back to GetFilings.com



Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

x    QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 27, 2004

Commission file number 000-49602

SYNAPTICS INCORPORATED

(Exact name of Registrant as specified in its charter)
     
Delaware   77-0118518

 
 
 
(State or other jurisdiction
of incorporation or organization)
  (I.R.S. Employer
Identification No.)

2381 Bering Drive
San Jose, California 95131


(Address of principal executive offices) (Zip code)

(408) 434-0110


(Registrant’s telephone number, including area code)

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x    No   o

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act). Yes x    No   o

Number of shares of Common Stock outstanding at May 4, 2004: 24,834,789

 


Table of Contents

SYNAPTICS INCORPORATED
QUARTERLY REPORT ON FORM 10-Q
FOR THE QUARTER ENDED MARCH 31, 2004

TABLE OF CONTENTS

                 
            Page
Part I.   Financial Information        
  Item 1.   Financial Statements (Unaudited):        
      Condensed Consolidated Balance Sheets- March 31, 2004 and June 30, 2003     3  
      Condensed Consolidated Statements of Operations- Three Months and Nine Months Ended March 31, 2004 and 2003     4  
      Condensed Consolidated Statements of Cash Flows- Nine Months Ended March 31, 2004 and 2003     5  
      Notes to Condensed Consolidated Financial Statements     6  
  Item 2.   Management’s Discussion and Analysis of Financial Condition and Results of Operations     11  
  Item 3.   Quantitative and Qualitative Disclosures About Market Risk     18  
  Item 4.   Controls and Procedures     18  
Part II.   Other Information        
    Item 6.Exhibits and Reports on Form 8-K     19  
Signatures         20  
 EX-31.1
 EX-31.2
 EX-32.1
 EX-32.2

 


Table of Contents

PART I — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share and per share data)
(unaudited)

                 
    March 31,   June 30,
    2004
  2003
ASSETS
               
Current Assets:
               
Cash and cash equivalents
  $ 55,494     $ 41,697  
Short-term investments
    35,291       35,589  
Restricted cash
    240       240  
Accounts receivable, net of allowances of $130 and $160, respectively
    18,808       13,181  
Inventories
    5,477       6,428  
Prepaid expenses and other current assets
    2,779       2,637  
 
   
 
     
 
 
Total current assets
    118,089       99,772  
Property and equipment, net
    1,976       1,934  
Goodwill
    1,891       1,968  
Other assets
    937       834  
 
   
 
     
 
 
 
  $ 122,893     $ 104,508  
 
   
 
     
 
 
LIABILITIES AND STOCKHOLDERS’ EQUITY
               
Current liabilities:
               
Accounts payable
    8,300       6,893  
Accrued compensation
    3,632       2,808  
Accrued warranty
    891       1,002  
Income taxes payable
    4,788       1,661  
Other accrued liabilities
    2,638       3,362  
Capital leases and equipment financing obligations
    55       231  
 
   
 
     
 
 
Total current liabilities
    20,304       15,957  
Capital leases and equipment financing obligations, net of current portion
          28  
Note payable to a related party
    1,500       1,500  
Other liabilities
    843       759  
Stockholders’ equity:
               
Common stock; $0.001 par value; 60,000,000 shares authorized; 24,814,164 and 23,835,877 shares issued and outstanding, respectively
    25       24  
Additional paid-in capital
    83,111       78,761  
Deferred stock compensation
    (760 )     (1,184 )
Notes receivable from stockholders
          (20 )
Accumulated other comprehensive income
    14       100  
Retained earnings
    17,856       8,583  
 
   
 
     
 
 
Total stockholders’ equity
    100,246       86,264  
 
   
 
     
 
 
 
  $ 122,893     $ 104,508  
 
   
 
     
 
 

See notes to consolidated financial statements.

3


Table of Contents

SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)
(unaudited)

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Net revenue
  $ 34,284     $ 26,103     $ 98,129     $ 72,479  
Cost of revenue (1)
    19,726       15,385       57,286       41,745  
 
   
 
     
 
     
 
     
 
 
Gross margin
    14,558       10,718       40,843       30,734  
 
   
 
     
 
     
 
     
 
 
Operating expenses:
                               
Research and development (1)
    5,613       4,942       15,839       15,077  
Selling, general, and administrative (1)
    3,452       2,715       9,819       7,957  
Amortization of other acquired intangible assets
                      40  
Amortization of deferred stock compensation
    128       137       397       363  
Restructuring
                432        
 
   
 
     
 
     
 
     
 
 
Total operating expenses
    9,193       7,794       26,487       23,437  
 
   
 
     
 
     
 
     
 
 
Income from operations
    5,365       2,924       14,356       7,297  
Interest and other income, net
    246       259       701       815  
Interest expense
    (33 )     (35 )     (101 )     (121 )
 
   
 
     
 
     
 
     
 
 
Income before provision for income taxes
    5,578       3,148       14,956       7,991  
Provision for income taxes
    2,073       1,079       5,683       2,877  
 
   
 
     
 
     
 
     
 
 
Net income
  $ 3,505     $ 2,069     $ 9,273     $ 5,114  
 
   
 
     
 
     
 
     
 
 
Net income per share:
                               
Basic
  $ 0.14     $ 0.09     $ 0.38     $ 0.22  
 
   
 
     
 
     
 
     
 
 
Diluted
  $ 0.13     $ 0.08     $ 0.34     $ 0.21  
 
   
 
     
 
     
 
     
 
 
Shares used in computing net income per share:
                               
Basic
    24,671,358       23,537,666       24,266,653       23,407,637  
 
   
 
     
 
     
 
     
 
 
Diluted
    27,451,066       25,125,131       26,921,070       24,869,050  
 
   
 
     
 
     
 
     
 
 


(1)   Cost of revenue excludes $5,000, $7,000, $15,000, and $21,000 of amortization of deferred stock compensation for the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively. Research and development expense excludes $21,000, $38,000, $76,000, and $115,000 of amortization of deferred stock compensation for the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively. Selling, general, and administrative expenses exclude $102,000, $92,000, $306,000, and $227,000 of amortization of deferred stock compensation for the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively. These amounts have been aggregated and reflected as “Amortization of deferred stock compensation.”

See notes to consolidated financial statements.

4


Table of Contents

SYNAPTICS INCORPORATED AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)
(unaudited)

                 
    Nine Months Ended
    March 31,
    2004
  2003
Cash flows from operating activities
               
Net income
  $ 9,273     $ 5,114  
Adjustments to reconcile net income to net cash provided by operating activities:
               
Depreciation of property and equipment
    786       1,071  
Amortization of other acquired intangible assets
          40  
Amortization of deferred stock compensation
    397       363  
Fair value of options issued to consultants for services rendered
          17  
Changes in operating assets and liabilities:
               
Accounts receivable
    (5,627 )     (910 )
Inventories
    951       85  
Prepaid expenses and other current assets
    (142 )     (781 )
Other assets
    (103 )     10  
Accounts payable
    1,407       939  
Accrued compensation
    824       222  
Accrued warranty
    (111 )      
Income taxes payable
    3,127       404  
Other accrued liabilities
    (648 )     529  
Other liabilities
    84       57  
 
   
 
     
 
 
Net cash provided by operating activities
    10,218       7,160  
 
   
 
     
 
 
Cash flows from investing activities
               
Purchases of short-term investments
    (17,336 )     (18,144 )
Proceeds from sales and maturities of short-term investments
    17,548       3,569  
Purchase of property and equipment
    (828 )     (898 )
 
   
 
     
 
 
Net cash used in investing activities
    (616 )     (15,473 )
 
   
 
     
 
 
Cash flows from financing activities
               
Payments on capital leases and equipment financing obligations
    (204 )     (363 )
Proceeds from issuance of common stock upon exercise of options and stock purchase plan
    4,379       1,648  
Repayment of notes receivable from stockholders
    20       121  
 
   
 
     
 
 
Net cash provided by financing activities
    4,195       1,406  
 
   
 
     
 
 
Net increase (decrease) in cash and cash equivalents
    13,797       (6,907 )
Cash and cash equivalents at beginning of period
    41,697       45,491  
 
   
 
     
 
 
Cash and cash equivalents at end of period
  $ 55,494     $ 38,584  
 
   
 
     
 
 
Supplemental disclosures of cash flow information
               
Cash paid for interest
  $ 5     $ 22  
Cash paid for income taxes
    2,550       2,442  

See notes to consolidated financial statements

5


Table of Contents

SYNAPTICS INCORPORATED AND SUBSIDIARIES
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

1. Basis of Presentation

     The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission and generally accepted accounting principles. However, certain information or footnote disclosures normally included in financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In our opinion, the statements include all adjustments, which are of a normal and recurring nature, necessary for the fair presentation of the results of the interim periods presented. The results of operations for the interim periods are not necessarily indicative of the operating results for the full fiscal year or any future period. These financial statements should be read in conjunction with the audited consolidated financial statements and related notes included in our annual report on Form 10-K for the year ended June 30, 2003.

     The consolidated financial statements include our financial statements and our wholly owned subsidiaries. All significant intercompany balances and transactions have been eliminated upon consolidation.

     The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.

     On an on-going basis, we evaluate our estimates, including those related to revenue recognition, allowances for doubtful accounts, inventory, product warranties, and income taxes. These estimates are based on historical facts and various other assumptions we believe to be reasonable at the time the estimates are made.

     Our fiscal year ends on the last Saturday in June. For ease of presentation, the accompanying consolidated financial statements have been shown as ending on June 30 and calendar quarter ends for all annual, interim, and quarterly financial statement captions.

     We have elected to follow APB Opinion No. 25, “Accounting for Stock Issued to Employees,” and related interpretations in accounting for stock options. Had compensation expense for stock options been determined based on the fair value of the option at date of grant consistent with the provisions of Statement of Financial Accounting Standard No. 123, “Accounting for Stock-Based Compensation,” net income and earnings per share would have been reduced to the pro forma amounts indicated below (in thousands, except per share amounts):

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Net income — as reported
  $ 3,505     $ 2,069     $ 9,273     $ 5,114  
Add: Total stock-based employee compensation included in reported net income, net of related tax
    79       137       244       363  
Deduct: Total stock-based employee compensation determined under fair value based method for all awards, net of related tax
    (1,156 )     (778 )     (3,017 )     (2,018 )
 
   
 
     
 
     
 
     
 
 
Net income — pro forma
  $ 2,428     $ 1,428     $ 6,500     $ 3,459  
 
   
 
     
 
     
 
     
 
 
Net income per share — Basic:
                               
As reported
  $ 0.14     $ 0.09     $ 0.38     $ 0.22  
 
   
 
     
 
     
 
     
 
 
Pro forma
  $ 0.10     $ 0.06     $ 0.27     $ 0.15  
 
   
 
     
 
     
 
     
 
 
Net income per share — Diluted:
                               
As reported
  $ 0.13     $ 0.08     $ 0.34     $ 0.21  
 
   
 
     
 
     
 
     
 
 
Pro forma
  $ 0.09     $ 0.06     $ 0.24     $ 0.14  
 
   
 
     
 
     
 
     
 
 

     The fair value of each award granted was estimated at the date of grant using a Black-Scholes option-pricing model, assuming no expected dividends and the following weighted average assumptions:

6


Table of Contents

                                 
                    Employee Stock
    Stock Options
  Purchase Plan
    Three Months Ended   Three Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Expected volatility
    79.1 %     84.5 %     68.2 %     84.5 %
Expected life in years
    5       5       0.4       0.4  
Risk-free interest rate
    2.8 %     2.8 %     1.0 %     1.1 %
Weighted average fair value
  $ 10.38     $ 4.90     $ 2.65     $ 2.73  
                                 
                    Employee Stock
    Stock Options
  Purchase Plan
    Nine Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Expected volatility
    71.6 %     84.5 %     65.0 %     84.5 %
Expected life in years
    5       5       0.4       0.4  
Risk-free interest rate
    2.8 %     2.8 %     1.0 %     1.1 %
Weighted average fair value
  $ 8.00     $ 4.21     $ 2.57     $ 2.86  

2. Revenue Recognition

     We recognize revenue from product sales when there is persuasive evidence that an arrangement exists, delivery has occurred and title has transferred, the price is fixed and determinable, and collectibility is reasonably assured. We accrue for estimated sales returns and other allowances at the time we recognize revenue, which is typically upon shipment, based on historical experience. Contract revenue for research and development is recorded as earned based on the performance requirements of the contract. Non-refundable contract fees for which no further performance obligations exist, and for which there is no continuing involvement by us, are recognized on the earlier of when the payments are received or when collection is assured.

3. Net Income Per Share

     Basic net income per share amounts have been computed using the weighted average number of shares of common stock outstanding during each period. Diluted net income per share amounts also include the effect of potentially dilutive securities, including stock options, when dilutive.

     The following table presents the computation of basic and diluted net income per share (in thousands, except per share amounts):

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Numerator for basic and diluted net income per share:
                               
Net income
  $ 3,505     $ 2,069     $ 9,273     $ 5,114  
 
   
 
     
 
     
 
     
 
 
Denominator for basic net income per share:
                               
Weighted average common shares outsanding
    24,671       23,537       24,267       23,407  
 
   
 
     
 
     
 
     
 
 
Denominator for basic net income per share
    24,671       23,537       24,267       23,407  
 
   
 
     
 
     
 
     
 
 
Denominator for diluted net income per share:
                               
Shares used above, basic
    24,671       23,537       24,267       23,407  
Effect of dilutive stock options
    2,780       1,588       2,654       1,462  
 
   
 
     
 
     
 
     
 
 
Denominator for diluted net income per share
    27,451       25,125       26,921       24,869  
 
   
 
     
 
     
 
     
 
 
Net income per share:
                               
Basic
  $ 0.14     $ 0.09     $ 0.38     $ 0.22  
 
   
 
     
 
     
 
     
 
 
Diluted
  $ 0.13     $ 0.08     $ 0.34     $ 0.21  
 
   
 
     
 
     
 
     
 
 

7


Table of Contents

     Options to purchase 19,000, 1,415,923, 125,720, and 1,286,224 shares of common stock that were outstanding during the three months ended March 31, 2004 and 2003, and the nine months ended March 31, 2004 and 2003, respectively, were not included in the computation of diluted earnings per share for these periods because the options’ exercise prices were greater than the average market price of our common stock during these periods, and therefore, their effect would have been antidilutive.

4. Cash Equivalents and Short-term Investments

     Cash equivalents consist of highly liquid investments with original maturities of three months or less. Short-term investments consist of marketable securities and are classified as securities “available for sale” under Statement of Financial Accounting Standards No. 115, “Accounting for Certain Investments in Debt and Equity Securities”. Such securities are reported at fair value, with unrealized gains and losses, net of taxes, excluded from earnings and shown separately as a component of accumulated other comprehensive income within stockholders’ equity. Interest earned on marketable securities is included in interest income. Realized gains and losses on the sale of marketable securities are determined using the specific identification method.

5. Restructuring

     In late June 2003, we completed the acquisition of NSM Technology Limited (NSM), a Hong Kong company. In conjunction with the acquisition of NSM, duplicate operational positions were identified at our San Jose and Taiwan locations. During the three months ended September 30, 2003, we recorded $432,000 related to the elimination of those positions as restructuring charges. There were no restructuring charges for the three months ended March 31, 2004 and 2003 and the nine months ended March 31, 2003. The restructuring expenses consisted primarily of severance costs for the terminated employees who were notified in early July 2003.

6. Inventories

     Inventories are stated at the lower of cost (first-in, first-out method) or market (estimated net realizable value) and consisted of the following (in thousands):

                 
    March 31,   June 30,
    2004
  2003
Raw materials
  $ 5,205     $ 6,062  
Finished goods
    272       366  
 
   
 
     
 
 
 
  $ 5,477     $ 6,428  
 
   
 
     
 
 

     Write-downs to reduce the carrying value of obsolete, slow moving, and non-usable inventory to its net realizable value are charged to cost of revenue.

7. Goodwill

     The carrying amount of goodwill was as follows (in thousands):

                 
    March 31,   June 30,
    2004
  2003
NSM acquisition
  $ 1,125     $ 1,202  
ASL acquisition
    766       766  
 
   
 
     
 
 
 
  $ 1,891     $ 1,968  
 
   
 
     
 
 

8. Product Warranties and Indemnifications

     We generally warrant our products for a period of 12 to 37 months from the date of sale and estimate probable product warranty costs at the time revenue is recognized. Factors that affect our warranty liability include historical and anticipated rates of warranty claims, material usage, and service delivery costs. We assess the adequacy of our warranty obligations periodically and adjust the accrued warranty liability on the basis of our estimates.

8


Table of Contents

     Changes in our warranty liability for the nine-month periods ended March 31, 2004 and 2003 were as follows (in thousands):

                 
    Nine Months Ended
    March 31,
    2004
  2003
Beginning accrued warranty
  $ 1,002     $ 1,002  
Provision for product warranties
    384       37  
Cost of warranty claims
    (495 )     (37 )
 
   
 
     
 
 
Ending accrued warranty
  $ 891     $ 1,002  
 
   
 
     
 
 

     In connection with certain third-party agreements we have executed in the past, we are obligated to indemnify the third party in connection with any technology infringement by us. Maximum potential future payments cannot be estimated because these agreements do not have a maximum stated liability. However, historical costs related to these indemnification provisions have not been significant. We have not recorded any liability in our consolidated financial statements for such indemnification.

9. Income Taxes

     The income tax provision for the nine-month periods ended March 31, 2004 and 2003 reflects an effective income tax rate based on expected pre-tax income for the year partially offset by a research and development tax credit. The effective tax rates for the nine months ended March 31, 2004 and 2003 were approximately 38.0% and 36.0%, respectively, and represent a lower percentage than the combined federal and state statutory rate primarily due to the benefit of research and development tax credits and tax exempt interest income.

10. Segment, Customers, and Geographic Information

     We operate in one segment, the development, marketing, and sale of interactive user interface solutions for intelligent electronic devices and products, and currently generate our revenue primarily from companies in the personal computer (“PC”) market.

     The following is a summary of operations within geographic areas based on the customer location (in thousands):

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Revenue from sales to unaffiliated customers:
                               
China
  $ 20,629     $ 11,588     $ 52,457     $ 41,947  
Taiwan
    8,085       8,296       29,834       16,112  
Other
    5,570       6,219       15,838       14,420  
 
   
 
     
 
     
 
     
 
 
 
  $ 34,284     $ 26,103     $ 98,129     $ 72,479  
 
   
 
     
 
     
 
     
 
 

     Major customer data as a percentage of total revenue:

                                 
    Three Months Ended   Nine Months Ended
    March 31,
  March 31,
    2004
  2003
  2004
  2003
Customer A
    31 %     12 %     24 %     11 %
Customer B
    *       *       10 %     *  

     Major customer data as a percentage of total accounts receivable:

                   
    March 31,   June 30,
    2004
  2003
Customer A
    35 %     26 %


*   Less than 10%

9


Table of Contents